Thursday, July 27, 2006

Insulin from safflowers

A Canadian company has announced the successful production of commercial quantities of human insulin from bioengineered safflowers.

This is important news for diabetics, because worldwide demand for insulin is increasing relentlessly. By 2010, total demand is projected to rise to 16,000 kg from 5,000 kg in 2005—a 320% increase in only five years.

Here are previous postings about green tea and diabetes.

—Mellow Monk

Go to the Mellow Monk tea page
Bookmark this blog
Subscribe to the blog feed (RSS)